TherapeuticsMD, Inc. Quarterly Operating Income (Loss) in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
TherapeuticsMD, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q2 2024.
  • TherapeuticsMD, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.44M, a 1.29% increase year-over-year.
  • TherapeuticsMD, Inc. annual Operating Income (Loss) for 2023 was -$8.52M, a 816% decline from 2022.
  • TherapeuticsMD, Inc. annual Operating Income (Loss) for 2022 was $1.19M.
  • TherapeuticsMD, Inc. annual Operating Income (Loss) for 2021 was -$79.6M, a 48.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.44M +$32K +1.29% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q4 2023 -$8.52M -$1.61M -$50.1M -103% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $41.5M -$1.77M +$12.7M +87.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $28.8M -$2.47M +$12.4M +83.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $16.4M -$2.67M +$15.2M +85.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.19M $48.4M +$83.8M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$82.6M -$14.5M +$25.4M +63.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$108M -$14.9M +$20.3M +57.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$128M -$17.9M +$11.4M +38.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$140M -$35.4M -$785K -2.27% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-23
Q3 2021 -$139M -$39.9M -$14.9M -59.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$124M -$35.2M +$9.86M +21.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$134M -$29.3M +$21.6M +42.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$156M -$34.6M +$9.78M +22% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$165M -$25M +$2.1M +7.75% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-23
Q2 2020 -$167M -$45M -$3.4M -8.17% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-23
Q1 2020 -$164M -$50.9M -$12.8M -33.6% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-23
Q4 2019 -$151M -$44.4M -$6.27M -16.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-23
Q3 2019 -$145M -$27.1M +$7.29M +21.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$152M -$41.6M -$8.61M -26.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$144M -$38.1M -$13.4M -54.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$130M -$38.1M -$16.4M -75.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-04
Q3 2018 -$114M -$34.4M -$19.5M -132% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$94.3M -$33M -$13.2M -66.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$81.1M -$24.7M -$3.43M -16.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$77.6M -$21.7M +$1.26M +5.49% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 -$78.9M -$14.8M +$10.3M +41% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$89.2M -$19.8M +$1.38M +6.51% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-30
Q1 2017 -$90.6M -$21.3M -$313K -1.49% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 -$90.3M -$22.9M -$5.43M -31% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$84.8M -$25.1M -$5.63M -28.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$79.2M -$21.2M +$6.04M +22.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$85.2M -$21M -$50.9K -0.24% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$85.2M -$17.5M -$1.19M -7.32% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-23
Q3 2015 -$84M -$19.5M -$1.66M -9.27% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$82.3M -$27.3M -$16.3M -149% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$66M -$20.9M -$12M -134% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$54M -$16.3M -$8.3M -104% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 -$45.7M -$17.8M -$10.6M -147% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$35.1M -$10.9M -$5.31M -94.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$29.8M -$8.95M -$4.01M -81.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$25.8M -$8.01M -$2.62M -48.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$23.2M -$7.24M -$3.33M -85.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$19.9M -$5.62M -$1.64M -41.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$18.2M -$4.94M -$2.07M -72.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 -$16.1M -$5.4M -$3.23M -150% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$12.9M -$3.91M -$2.47M -171% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 -$10.4M -$3.97M -$2.92M -278% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$7.52M -$2.87M -$2.1M -272% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$5.43M -$2.16M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-05
Q3 2011 -$1.44M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$1.05M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$771K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.